JPRN-jRCT2080221608未知2 期
Phase II Study of KRP-209 - A Clinical Trial to Evaluate Efficacy and Safety of KRP-209 in Patients with Subjective Tinnitus
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Patients with a clinical diagnosis of first onset, persistent (i.e. tinnitus should never be absent for >24 hours in a row), subjective, uni- or bilateral tinnitus. In case of bilateral tinnitus this criterion applies to both ears.
排除标准
- •- Clinical diagnosis of intermittent or pulsatile tinnitus.
- •- Patients who have tinnitus as a concomitant sympton of a middle ear disease(such as otitis media, otosclerosis, eustachian tube dysfunction, etc), fluctuant hearing impairment(such as Meniere's disease, etc), retrocochlear hearingloss(such as acoustic neuroma), arteriovenous malformation or glomus tumor.
研究者
相似试验
未知
2 期
Exploratory Phase II Study of KRP-203 -A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of KRP-203 in Patients with Crohn's Disease in Active PhaseCrohn's DiseaseJPRN-jRCT2080222062Kyorin Pharmaceutical Co.,LTD60
未知
2 期
KRP-104Phase 2 Dose Finding Study -Investigation on Type2 Diabetes MellitusJPRN-jRCT2080220708Kyorin Pharmaceutical Co.,LTD
未知
2 期
K012 phase II clinical studyColorectal cancerJPRN-jRCT2080220752ippon Kayaku Co., Ltd.
未知
3 期
KRP-108 comparative studyAsthmaJPRN-jRCT2080221303Kyorin Pharmaceutical Co.,LTD
进行中（未招募）
不适用
Phase II Study of ZK 219 477 in patients with recurrent glioblastoma - Epothilone in GBMEUCTR2006-001659-37-ITE.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER35